Antiparasitic agents

Mayo Clinic Proceedings

Volumn 74, Issue 11, 1999, Pages 1161-1174

  Rosenblatt, Jon E ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIPARASITIC AGENT; ARTEMETHER; ARTEMISININ; ARTESUNATE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; HALOFANTRINE; IVERMECTIN; MEBENDAZOLE; MEFLOQUINE; METRONIDAZOLE; PAROMOMYCIN; PENTAMIDINE; PENTAMIDINE ISETHIONATE; PRAZIQUANTEL; PYRANTEL EMBONATE; PYRIMETHAMINE; QUININE; STIBOGLUCONATE SODIUM; SULFADIAZINE; TETRACYCLINE; TIABENDAZOLE; UNINDEXED DRUG;

BABESIOSIS; BIRTH DEFECT; CHEMOTHERAPY; CONFERENCE PAPER; CRYPTOSPORIDIOSIS; DRUG CHOICE; ECHINOCOCCOSIS; FOOD AND DRUG ADMINISTRATION; HUMAN; MALARIA FALCIPARUM; MICROSPORIDIOSIS; MULTIDRUG RESISTANCE; NEMATODIASIS; NEUROCYSTICERCOSIS; PARASITOSIS; PLASMODIUM FALCIPARUM; PREGNANCY; PROPHYLAXIS; SIDE EFFECT; STILLBIRTH; TOXOPLASMOSIS; VISCERAL LEISHMANIASIS;

EID: 0033508358     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.11.1161     Document Type: Conference Paper

References (41)

1. Smith NH, Cron S, Valdez LM, Chappell CL, White AC Jr. Combination drug therapy for cryptosporidiosis in AIDS. JlnfectDis 1998:178:900-903
2. RavdinJI. Amebiasis. Clin Infect Dis 1995:20:1453-1464
3. Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis 1997:25:545-549
4. Didier ES. Microsporidiosis. Clin Infect Dis 1998:27:1-7
5. Denney CF, Iragui VJ, Uber-Zak LD, Karpinskl NC, Ziegler EJ, Visvesvara GS, et al. Amebic mëningoencephalitis caused by Balamuthia mandrillaris: case report and review. Clin Infect Dis 1997:25:1354-1358
6. Larkin DF, Kllvlngton S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992:99:185-191
7. Shlh CM, Wang CC. Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans. Am J TropMed Hyg 1998:59:509-512
8. Dobroszyckl J, Herwaldt BL, Boctor F, Miller JR, Linden J, Eberhard ML, et al. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA 1999:281:927-930
9. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemctherapeutic developments in the last 10 years. Clin Infect Dis 1997:24:684-703
10. Sundar S, Singh VP, Sharma S, Makharia MK, Murray HW. Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. JlnfectDis 1997:176:1117-1119
11. Herwaldt BL. Leishmaniasis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors. Harrison's Principles of Internal Medicine. Vol 1. 14th ed. New York: McGrawHill; 1998. pp 1189-1193
12. Whitby M. Drug resistant Plasmodium vivax malaria. J Antimicrob Chemother 1997:40:749-752
13. Kremsner PG, Wildling E, Jenne L, Graninger W, Bienzle U. Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon. Am J Trop Med Hyg 1994;50:790-795
14. van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335:69-75
15. Tran TH, Day NPJ, Nguyen HP, Nguyen THM, Tran THC, Pham PL, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996:335:76-83
16. Pittler MH, Ernst E. Artemether for severe malaria: a meta-analysis of randomized clinical trials. Clin Infect Dis 1999:28:597-601
17. de Alencar FEC, Ceruttl C Jr, Durlacher RR, Boulos M, Alves FP, Milhous W, et al. Atovaquone and proguanil for the treatment of malaria in Brazil. JlnfectDis 1997:175:1544-1547
18. Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, et al. Efficacy and safety of atovaquone/proguanil as suppressive pro-phylaxis for Plasmodium falciparum malaria. Clin Infect Dis 1998;27:494-499
19. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al (New England Regional Toxoplasma Working Group). Neonatal sérologie screening and early treatment for congenital Toxoplasma gondii infection. N Engt J Med 1994:330:1858-1863
20. Torres RA, Weinberg W, Stansell J, Leoung G, Kovacs J, Rogers M. et al (Atovaquone/Toxoplasmic Encephalitis Study Group). Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1997:24:422-429
21. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 1998:59:526-529
22. Apt W, Aguilera X, Arribada A, Ferez C, Miranda C, Sanchez G, et al. Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am J Trop Med Hyg 1998:59:133-138
23. Barren MP. The fall and rise of sleeping sickness. Lancet 1999; 353:1113-1114
24. Eflornithine triai results. TOR News 1998:57:1-2
25. Addiss DG, Beach MJ, Streit TG, Lutwlck S, LeConte FH, Lafontant JG, et al. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children [published erratum appears in /Lancet 1997:350:1036]. Lancet 1997:350:480-484
26. Ottesen EA, Campbell WC. Ivermectin in human medicine. J Antimicrob Chemother 1994:34:195-203
27. Calvopina M, Guderian RH, Paredes W, Chico M, Cooper PJ. Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans R Soc Trop Med Hyg 1998; 92:566-569
28. Cobo F, Yarnoz C, Sesma B, Fraile P, Aizcorbe M, Trujillo R, et al. Albendazole plus praziquantel versus albendazole alone as a preoperative treatment in intra-abdominai hydatidosis caused by Echinococcus granulosus. Trop Med Int Health 1998:3:462-466
29. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24:101-113
30. Bell TA. Treatment of Pediculus humanus var. capitis infestation in Cowlitz County, Washington, with ivermectin and the LiceMeister comb. Pediatr Infect Dis J 1998:17:923-924
31. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 1998;2:152-154
32. Lobel HO, Kozarsky PE. Update on prevention of malaria for travelers. JAMA 1997:278:1767-1771
33. Nosten F, Vincent! M, Simpson J, Yei P, Thwai KL, de Vries A, et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 1999;28:808-815
34. Touze JE, Bernard J, Keundjian A, Imbert P, Viguier A, Chaudet H, et al. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. Am J Trop Med Hyg 1996:54:225-228
35. Miller LG, Panosian CB. Ataxia and slurred speech after artesunate treatment for falciparum malaria [letter]. W Engl J Med 1997;336: 1328
36. Nontprasert A, Nosten-Bertrand M, Pukrittayakamee S, Vanijanonta S, Angus BJ, White NJ. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice. Am J Trop Med Hyg 1998;59:519-522
37. Meyerhoff A. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999:28:42-48
38. VenkatesanP. Albendazole. J Antimicrob Chemother 1998:41:145-147
39. Torres JR, Isturiz R, Murillo J, Guzman M, Contreras R. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 1993:17:900-902
40. Carpio A, Santlllan F, Leon P, Bores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995;155:1982-1988
41. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998:17:696-700